Quantification of abemaciclib and metabolites: Evolution of bioanalytical methods supporting a novel oncolytic agent
Aim: Bioanalytical methods undergo many revisions and modifications throughout drug development to meet the objectives of the study and development program. Results: Validated LC-MS/MS methodology used to quantify abemaciclib and four metabolites in human plasma is described. The method, initially v...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Future Medicine Ltd.
2021
|
| Subjects: | |
| Online Access: | View Fulltext in Publisher |